CVC  CVS Health Ventures

https://www.cvshealth.com/health-care-redefin ed/ventures.html





     Office Locations:

Boston, MA

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage companies focused on making health care more accessible, affordable and simpler. CVS focuses on investments that support the overall vision and strategy of CVS Health: Transforming care delivery, Whole person care, Consumer-centric health, and Disruptive technology enablement. According to published reports, the CVS Health Ventures launched with a $100 million fund.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alyssa Reisner Lead Director and Investment Principal
    Vijay Patel Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      10/18/2024


      Oshi Health


      NY


      $60,000,000


      Series C


      07/16/2024


      Thyme Care


      TN


      $95,000,000


      Series C


      05/21/2024


      Wayspring


      TN


      undisclosed


      Venture


      02/23/2024


      Abridge


      PA


      $150,000,000


      Series C


     

    Portfolio companies include:


      Abridge


      Array Behavioral Care
        web link


      Biofourmis
        web link


      Carbon Health
        web link


      Cortica
        web link


      Maven


      Monogram Health
        web link


      Oshi Health
        web link


      Oui Therapeutics


      SpectrumAi
        web link


      Thyme Care
        web link


      Vita Health


      Wayspring
        web link


      Workit Health
        web link


     

    Recent News: